Literature DB >> 28419259

Adjunctive Corticosteroid Therapy in the Treatment of Coccidioidal Meningitis.

George R Thompson1,2, Janis E Blair3, Sharon Wang2, Robert Bercovitch4, Michael Bolaris5, Dane Van Den Akker6, Rodrigo Lopez7, Arash Heidari8, Antonino Catanzaro4, Jose Cadena7,9, Peter Chin-Hong10, Brad Spellberg11, Royce Johnson8.   

Abstract

Coccidioidal meningitis (CM) has high morbidity, and adjunctive measures to improve outcomes are needed. Using an established multicenter retrospective cohort study of CM (N = 221), we found that patients receiving adjunctive corticosteroids had a significant reduction in secondary cerebrovascular events (P = .0049). Those with CM-associated cerebrovascular events (8%) may benefit from short-term corticosteroids.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  coccidioidomycosis; corticosteroids; meningitis; stroke; vasculitis

Mesh:

Substances:

Year:  2017        PMID: 28419259      PMCID: PMC5850006          DOI: 10.1093/cid/cix318

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  25 in total

1.  Vasculitic and encephalitic complications associated with Coccidioides immitis infection of the central nervous system in humans: report of 10 cases and review.

Authors:  P L Williams; R Johnson; D Pappagianis; H Einstein; U Slager; F T Koster; J J Eron; J Morrison; J Aguet; M E River
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

2.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

3.  The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis.

Authors:  E Tuomanen; A Tomasz; B Hengstler; O Zak
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

4.  Temporal expression of inflammatory mediators in brain basilar artery vasculitis and cerebrospinal fluid of rabbits with coccidioidal meningitis.

Authors:  K E Zucker; P Kamberi; R A Sobel; G Cloud; D N Meli; K V Clemons; D A Stevens; P L Williams; S L Leib
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

5.  Tumor necrosis factor-alpha and interleukin-1 beta in cerebrospinal fluid of patients with coccidioidal meningitis during therapy with fluconazole. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Authors:  N M Ampel; D R Ahmann; K L Delgado; J N Galgiani; G A Cloud
Journal:  J Infect Dis       Date:  1995-06       Impact factor: 5.226

6.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

7.  Coccidioidal meningitis complicated by cerebral arteritis and infarction.

Authors:  C A de Carvalho; J N Allen; A Zafranis; A J Yates
Journal:  Hum Pathol       Date:  1980-05       Impact factor: 3.466

Review 8.  Routine CSF analysis in coccidioidomycosis is not required.

Authors:  George Thompson; Sharon Wang; Robert Bercovitch; Michael Bolaris; Dane Van Den Akker; Sandra Taylor; Rodrigo Lopez; Antonio Catanzaro; Jose Cadena; Peter Chin-Hong; Brad Spellberg
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

9.  Increase in reported coccidioidomycosis--United States, 1998-2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-03-29       Impact factor: 17.586

Review 10.  Corticosteroids for managing tuberculous meningitis.

Authors:  Kameshwar Prasad; Mamta B Singh; Hannah Ryan
Journal:  Cochrane Database Syst Rev       Date:  2016-04-28
View more
  5 in total

Review 1.  Coccidioidal Meningitis: A Review on Diagnosis, Treatment, and Management of Complications.

Authors:  Royce Johnson; Jackie Ho; Pete Fowler; Arash Heidari
Journal:  Curr Neurol Neurosci Rep       Date:  2018-03-13       Impact factor: 5.081

Review 2.  Modulating host immune responses to fight invasive fungal infections.

Authors:  James E Scriven; Mark W Tenforde; Stuart M Levitz; Joseph N Jarvis
Journal:  Curr Opin Microbiol       Date:  2017-11-15       Impact factor: 7.934

Review 3.  Central Nervous System Infections Due to Coccidioidomycosis.

Authors:  Niki R Jackson; Janis E Blair; Neil M Ampel
Journal:  J Fungi (Basel)       Date:  2019-06-28

4.  Crescendo Transient Ischemic Attacks Due to Basilar Coccidioidal Meningitis With Coccidioma.

Authors:  Carlos D'Assumpcao; Arash Heidari; Katayoun Sabetian; Royce H Johnson
Journal:  J Investig Med High Impact Case Rep       Date:  2018-11-19

5.  Pandora's Box: Disseminated Coccidioidomycosis Associated with Self-Medication with an Unregulated Potent Corticosteroid Acquired in Mexico.

Authors:  Alejandro Jose Coba; Patricia K Sallee; Danielle O Dixon; Rahaf Alkhateb; Gregory M Anstead
Journal:  Trop Med Infect Dis       Date:  2021-12-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.